Mendelian randomization analysis on GLP-1RA with 12 psychiatric and neurodevelopmental conditions Mendelian randomization (MR) analysis across multiple independent GWAS datasets, including FinnGen, PGC, UK Biobank, and other large consortia, revealed a consistent protective association between higher GLP-1R gene expression and several psychiatric and neurodevelopmental conditions
At 8mg, the Phase 2 trial showed 22.8% body weight reduction at 48 weeks
It clarifies that
A variety of scientific research has pointed to its ability to support cardiovascular, reproductive and muscular health
Its a straightforward process, but knowing this can help alleviate any confusion you might have
HEK293T cells in 12-well plates were transfected with 0.5 g GLP-1R-SmBiT plus 0.5 g LgBiT-mini-G s (Wan et al ., 2018) (a gift from Prof Nevin Lambert, Medical College of Georgia, USA), or with 0.05 g GLP-1R-SmBiT and 0.05 g LgBit--arrestin-2 (Promega, Hampshire, UK) plus 0.9 g pcDNA3.1 for 24 hours